ArticleClinical immunology (Orlando, Fla.)2021

Response to "Comment on Mastellos and colleagues and efficacy of complement-targeting drugs in COVID-19".

Dimitrios C Mastellos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.